Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,140 | -28,728 | -21,549 | -10,831 | -66,084 |
| Depreciation Amortization | 1,624 | 1,141 | 722 | 355 | 2,099 |
| Income taxes - deferred | 28 | N/A | N/A | N/A | 32 |
| Accounts receivable | 497 | 1,680 | 425 | 583 | -2,435 |
| Other Working Capital | 1,404 | 177 | 1,416 | 1,369 | 1,264 |
| Other Operating Activity | 2,764 | 3,981 | 5,280 | 2,966 | 49,742 |
| Operating Cash Flow | $-29,824 | $-21,749 | $-13,706 | $-5,557 | $-15,381 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -34,432 | -11,387 | -1,387 | 900 | -11,060 |
| PPE Investments | -1,380 | -1,208 | -887 | -182 | -177 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | 2,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 2,000 |
| Investing Cash Flow | $-35,812 | $-12,595 | $-2,274 | $719 | $-9,237 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 72,462 | 71,295 | 70,797 | 69,891 | 52,692 |
| Financing Cash Flow | $72,462 | $71,295 | $70,797 | $69,891 | $52,692 |
| Exchange Rate Effect | -2 | -2 | -2 | -2 | 0 |
| Beginning Cash Position | 33,720 | 33,720 | 33,720 | 33,720 | 5,646 |
| End Cash Position | 40,544 | 70,669 | 88,535 | 98,771 | 33,720 |
| Net Cash Flow | $6,824 | $36,949 | $54,815 | $65,051 | $28,074 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,824 | -21,749 | -13,706 | -5,557 | -15,381 |
| Capital Expenditure | -1,380 | -1,208 | -887 | -182 | -177 |
| Free Cash Flow | -31,204 | -22,957 | -14,593 | -5,739 | -15,558 |